Authors: Shawver, LK Lipson, KE Fong, TAT McMahon, G Strawn, LM

Citation: Lk. Shawver et al., Receptor tyrosine kinases in angiogenesis, NEW ANGIOTHERAPY, 2002, pp. 409-452

Authors: Furge, KA Kiewlich, D Le, P Vo, MN Faure, M Howlett, AR Lipson, KE Woude, GFV Webb, CP

Citation: Ka. Furge et al., Suppression of Ras-mediated tumorigenicity and metastasis through inhibition of the Met receptor tyrosine kinase, P NAS US, 98(19), 2001, pp. 10722-10727

Authors: Yamasaki, Y Miyoshi, K Oda, N Watanabe, M Miyake, H Chan, J Wang, XY Sun, L Tang, C McMahon, G Lipson, KE

Citation: Y. Yamasaki et al., Weekly dosing with the platelet-derived growth factor receptor tyrosine kinase inhibitor SU9518 significantly inhibits arterial stenosis, CIRCUL RES, 88(6), 2001, pp. 630-636

Authors: Krystal, GW Honsawek, S Kiewlich, D Liang, CX Vasile, S Sun, L McMahon, G Lipson, KE

Citation: Gw. Krystal et al., Indolinone tyrosine kinase inhibitors block kit activation and growth of small cell lung cancer cells, CANCER RES, 61(9), 2001, pp. 3660-3668

Authors: Lane, ME Yu, B Rice, A Lipson, KE Liang, C Sun, L Tang, C McMahon, G Pestell, RG Wadler, S

Citation: Me. Lane et al., A novel cdk2-selective inhibitor, SU9516, induces apoptosis in colon carcinoma cells, CANCER RES, 61(16), 2001, pp. 6170-6177

Authors: Greenspan, PD Fujimoto, RA Marshall, PJ Raychaudhuri, A Lipson, KE Zhou, HH Doti, RA Coppa, DE Zhu, LJ Pelletier, R Uziel-Fusi, S Jackson, RH Chin, MH Kotyuk, BL Fitt, JJ

Citation: Pd. Greenspan et al., Carboxy-substituted cinnamides: A novel series of potent, orally active LTB4 receptor antagonists, J MED CHEM, 42(1), 1999, pp. 164-172